NOTE AGGIUNTIVE

Parte dei risultati esposti nel corso di questa tesi sono stati oggetto di due lavori ai quali ho partecipato attivamente durante il periodo di dottorato: “Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression” (The European Journal of Neuroscience, 2007); “Antiangiogenic role of somatostatin receptor 2 in

a model of hypoxia-induced neovascularization in the retina: results from transgenic mice” (Investigative Ophthalmology & Visual Science. 2007).

Oltre al principale argomento di ricerca del mio dottorato esposto nel corso di questa tesi, durante il periodo di dottorato mi sono occupato dello studio della modulazione somatostatinergica dei meccanismi che regolano l’epilessia. I risulati di tale studio hanno contribuito alla realizzazione di un lavoro di ricerca pubblicato su The European Journal of Neurosciece, dal titolo “Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission (2006)”.

10. BIBLIOGRAFIA

Agardh CD, Gustavsson C, Hagert P, Nilsson M, Agardh E. (2006). Expression of antioxidant enzymes in rat retinal ischemia followed by reperfusion. Metabolism. 55:892-8.

Akopian A, Johnson J, Gabriel R, Brecha N, Witkovsky P. (2000). Somatostatin modulates voltage- gated K(+) and Ca(2+) currents in rod and cone photoreceptors of the salamander retina. J Neurosci. 20:929-36.

Allen JP, Hathway GJ, Clarke NJ, Jowett MI, Topps S, Kendrick KM, Humphrey PP, Wilkinson LS, Emson PC. (2003). Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur J Neurosci. 17:1881- 95.

Archer SN, Ahuja P, Caffé R, Mikol C, Foster RG, van Veen T, von Schantz M. (2004). Absence of phosphoglucose isomerase-1 in retinal photoreceptor, pigment epithelium and Muller cells. Eur J Neurosci. 19:2923-30.

Armani C, Catalani E, Balbarini A, Bagnoli P, Cervia D. (2007). Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol. 81:845-55. Epub 2006 Dec 5.

Arundine M. and Tymianski M. (2003). Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium. 34:325-37.

Asahi M, Hoshimaru M, Uemura Y, Tokime T, Kojima M, Ohtsuka T, Matsuura N, Aoki T, Shibahara K, Kikuchi H. (1997). Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery. J Cereb Blood Flow Metab. 17, 11-18.

Averbukh E, Weiss O, Halpert M, Yanko R, Moshe R, Nephesh I, Flyvbjerg A, Yanko L, Raz I. (1998). Gene expression of insulin-like growth factor-I, its receptor and binding proteins in retina under hypoxic conditions. Metabolism. 47:1331-6.

Ayoub GS. and Matthews G. (1992). Substance P modulates calcium current in retinal bipolar neurons. Vis Neurosci. 8:539–544.

Bagnoli P, Dal Monte M, Casini G. (2003). Expression of neuropeptides and their receptors in the developing retina of mammals. Histol Histopathol. 18:1219-42.

Baldysiak-Figiel A, Lang GK, Kampmeier J, Lang GE. (2004). Octreotide prevents growth factor- induced proliferation of bovine retinal endothelial cells under hypoxia. J Endocrinol. 180:417-24. Banai, S., Shweiki D., Pinson A., Chandra M., Lazarovici G., Keshet E. (1994). Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc. Res. 28:1176–1179.

Banerjee A, Roach MC, Wall KA, Lopata MA, Cleveland DW, Ludueña RF. (1988). A monoclonal antibody against the type II isotype of beta-tubulin. Preparation of isotypically altered tubulin. J Biol Chem. 263:3029-34.

Barber AJ. (2003). A new view of diabetic retino pathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 27:283-90.

Belzung C, Yalcin I, Griebel G, Surget A, Leman S. (2006). Neuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders. CNS Neurol Disord Drug Targets. 5:135-45.

Bigiani A, Petrucci C, Ghiaroni V, Dal Monte M, Cozzi A, Kreienkamp HJ, Richter D, Bagnoli P. (2004). Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Res. 1025:177-85.

Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO. (1999). Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am. J. Pathol. 155:421–428.

Blake AD, Badway AC, Strowski MZ. (2004). Delineating somatostatin's neuronal actions. Curr Drug Targets CNS Neurol Disord. 3:153-60.

Block F and Schwarz M. (1997). Effects of antioxidants on ischaemic retinal dysfunction. Exp Eye Res. 64: 559–564.

Bloomfield SA and Dacheux RF. (2001). Rod vision: pathways and processing in the mammalian retina. Prog. Retin. Eye Res. 20:351- 384.

Böcker-Meffert S, Rosenstiel P, Röhl C, Warneke N, Held-Feindt J, Sievers J, Lucius R. (2002). Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci. 43:2021-6.

Boehm BO, Lang GK, Jehle PM, Feldmann B, Lang GE. (2001). Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Hormone and Metabolic Research. 33:300–306.

Bosco A, Lerário AC, Soriano D, Dos Santos RF, Massote P, Galvão D, Franco AC, Purisch S, Ferreira AR. (2005). Diabetic retinopathy. Arq Bras Endocrinol Metabol. 2005. 49:217-27. Epub 2005 Sep 12-

Brandsta¨ tter JH, Koulen P, Wa¨ ssle H. (1997). Selective synaptic distribution of kainate receptor subunits in the two plexiform layers of the rat retina. J Neurosci. 17:9298–9307.

Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. Jan. 179:77-9.

Brecha N, Johnson D, Peichl L, Wässle H. (1988). Cholinergic amacrine cells of the rabbit retina contain glutamate decarboxylase and gamma-aminobutyrate immunoreactivity. Proc. Natl. Acad. Sci. 85:6187-6191

Brecha N. (2003). Peptide and peptide receptor expression and function in the vertebrate retina. In Chalupa, L.M., Werner, J.S. (eds.) The visual neurosciences. The MIT Press, Cambridge (MA). 334-354.

Brecha N, Sternini C, Humphrey M. (1991). Cellular distribution of L-glutamate decarboxylase (GAD) and gamma-aminobutyric acidA (GABAA) receptor mRNAs in the retina. Cell Mol Neurobiol. 11:497-509.

Bruns C, Shi V, Hoyer D, Schuurman H, Weckbecker G. (2000). Somatostatin receptors and the potential use of SandostatinR to interfere with vascular remodelling. European Journal of Endocrinology. 143 3–7.

Burren CP, Berka JL, Edmondson SR, Werther GA, Batch JA. (1996). Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. Invest Ophthalmol Vis Sci. 37:1459–1468.

Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, O’Carroll AM, Bell GI, Schally AV, Vaysse N, Susini C. (1995). Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. PNAS. 92:1580–1584.

Cabrera JL, de Freitas F, Satpaev DK, Slepak VZ. (1998). Identification of the Gbeta5-RGS7 protein complex in the retina. Biochem Biophys Res Commun. 249:898-902.

Cajal SR y. (1893). La re´tine des verte´bre´s. La Cellule. 9:119–257.

Camacho A. and Massieu L. (2006). Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch Med Res. 37:11-8.

Campochiaro PA. (2000). Retinal and choroidal neovascularization. J Cell Physiol. 184:301-10. Cao Y, Linden P, Shima D, Browne F, Folkman J. (1996). In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98:2507–2511.

Carmeliet P, Ferreira V,Breier G, Pollcfeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF. Nature. 380: 435–439.

Carmeliet P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389–395.

Carmeliet P. and Jain RK. (2000). Angiogenesis in cancer and other diseases. Nature. 407:249– 257.

Carrere N, Vernejoul F, Souque A, Asnacios A, Vaysse N, Pradayrol L, Susini C, Buscail L, Cordelier P. (2005). Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells. Hum Gene Ther. 16:1175-93.

Casini G, Catalani E, Dal Monte M, Bagnoli P. (2005). Functional aspects of the somatostatinergic system in the retina and the potential therapeutic role of somatostatin in retinal disease. Histol Histopathol. 20:615-32.

Casini G, Dal Monte M, Petrucci C, Gambellini G, Grouselle D, Allen JP, Kreienkamp HJ, Richter D, Epelbaum J, Bagnoli P. (2004). Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2. Eur J Neurosci. 19:43-54.

Casini G, Rickman DW, Brecha NC. (2006). Expression of the gamma-aminobutyric acid (GABA) plasma membrane transporter-1 in monkey and human retina. Invest Ophthalmol Vis Sci. 47:1682- 90.

Casson RJ, Chidlow G, Wood JP, Osborne NN. (2004). The effect of hyperglycemia on experimental retinal ischemia. Arch Ophthalmol. 122:361-6.

Celiker U. and Ilhan N. (2002). Nitric oxide and octreotide in retinal ischemia-reperfusion injury. Doc Ophthalmol. 105:327-38

Cervia D, Langenegger D, Schuepbach E, Cammalleri M, Schoeffter P, Schmid HA, Bagnoli P, Hoyer D. (2005). Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors. Neuropharmacology. 48:881-93.

Cervia D. and Bagnoli P. (2007). An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacol Ther. 116(2):322-341.

Charkrabarti S, Ghahary A, Murphy LJ, Sima AA. (1991). Insulin-like growth factor-I expression is not increased in the retina of diabetic BB/Wrats. Diabetes Res Clin Pract. 14:91–97.

Chen CK, Eversole-Cire P, Zhang H, Mancino V, Chen YJ, He W, Wensel TG, Simon MI. (2003). Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc Natl Acad Sci U S A. 100:6604-9. Epub 2003 May 8.

Chen DM, Xiao L, Cai X, Zeng R, Zhu XZ. (2006). Involvement of multitargets in paeoniflorin- induced preconditioning. J Pharmacol Exp Ther. 319:165-80. Epub 2006 Jul 13.

Chen J and Smith LR. (2007). Retinopathy of prematurity. Angiogenesis. 10:133-40.

Chen J, Nagayama T, Jin K, Stetler R, Zhu R, Graham, S, Simon R. (1998). Induction of caspase-3- like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci. 18:4914-4928.

Chernausek SD, Jacobs S, Van Wyk JJ. (1981). Structural similarities between human receptors for somatomedin c and insulin: analysis by affinity labeling.

Christensen RA, Fujikawa K, Madore R, Oettgen P, Varticovski L. (2002). NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia. J Cell Biochem. 85:505-15

Coelho JE, Rebola N, Fragata I, Ribeiro JA, de Mendonça A, Cunha RA. (2006). Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus. Neuroscience. 138:1195-203. Epub 2006 Jan 25.

Cole SL and Schindler M. (2000). Characterisation of somatostatin sst2 receptor splice variants. J Physiol Paris. (3-4):217-37.

Cristiani R, Fontanesi G, Casini G, Petrucci C, Viollet C, Bagnoli P. (2002a). Expression of somatostatin subtype 1 receptor in the rabbit retina. Invest Ophthalmol Vis Sci. 41:3191-9.

Cristiani R, Petrucci C, Dal Monte M, Bagnoli P. (2002b). Somatostatin (SRIF) and SRIF receptors in the mouse retina. Brain Res. 936:1-14.

Croiset G, Nijsen MJ, Kamphuis PJ. (2000). Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory.Eur J Pharmacol. 405:225-34.

Csaba Z, Bernard V, Helboe L, Bluet-Pajot MT, Bloch B, Epelbaum J, Dournaud P. (2001). In vivo internalization of the somatostatin sst2A receptor in rat brain: evidence for translocation of cell- surface receptors into the endosomal recycling pathway. Mol Cell Neurosci. 17:646–661.

Cui, Q, Yip HK, Zhao RC, S, KF, Harvey, AR. (2003). Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosi. 22:49-61.

D’Amato R, Wesolowski E, Smith LE. (1993). Microscopic visualization of the retina by angiography with high-molecular-weight fluoresceinlabeled dextrans in the mouse. Microvasc Res. 46:135–142.

Dal Monte M, Petrucci C, Cozzi A, Allen JP, Bagnoli P. (2003a). Somatostatin inhibits potassium- evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol. 367:188-192.

Dal Monte M, Petrucci C, Cozzi A, Allen JP, Bagnoli P. (2003b). Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. Neuropharmacology. 45:1080-92.

Danesi R, Agen C, Benelli U, Di Paolo A, Nardini D, Bocci G, Basolo F, Campagni A, Del Tacca M. (1997). Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS:201–995). Clinical Cancer Research 26:265–272.

Dasgupta P. (2004). Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis. Pharmacol Ther. 102:61–85.

Daugeliene L, Niwa M, Hara A, Matsuno H, Yamamoto T, Kitazawa Y, Uematsu T. (2002). Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion. Invest Ophthalmol Vis Sci. 41:2743-7.

de Almeida Gomes CP. and Ventura AL. (2004). Localization of G protein-coupled receptor kinases (GRKs) in the avian retina. Brain Res Bull. 63:499-507

Dejneka NS, Kuroki AM, Fosnot J, Tang W, Tolentino MJ, Bennett J. (2004). Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis. 10:964-72.

DeVries SH. (2000). Bipolar cells use kainate and AMPA receptors to filter visual information into separate channels. Neuron. 28:847–856.

Dicicco-Bloom E, Lu N, Pintar JE, Zhang J. (1998). The PACAP ligand/receptor system regulates cerebral cortical neurogenesis. Ann N Y Acad Sci. 865:274-89.

Dijk F. and Kamphuis W. (2004a). An immunocytochemical study on specific amacrine cell subpopulations in the rat retina after ischemia. Brain Res. 1026:205-217.

Dijk F. and Kamphuis W. (2004b). Ischemia-induced alterations of AMPA-type glutamate receptor subunit. Expression patterns in the rat retina—an immunocytochemical study. Brain Res. 997:207- 221.

Dijk F, Kraal-Muller E, Kamphuis W. (2004a). Ischemia-induced changes of AMPA-type glutamate receptor subunit expression pattern in the rat retina: a real-time quantitative PCR study. Invest Ophthalmol Vis Sc. 45:330-341.

Dijk F, van Leeuwen S, Kamphuis W. (2004b). Differential effects of ischemia/reperfusion on amacrine cell subtype-specific transcript levels in the rat retina. Brain Res. 1026:194-204.

Dilsiz N, Sahaboglu A, Yildiz MZ, Reichenbach A. (2006). Protective effects of various antioxidants during ischemia-reperfusion in the rat retina. Graefes Arch Clin Exp Ophthalmol. 244:627-33. Epub 2005 Oct 5.

Donovan EA. and Kummar S. (2007). Role of insulin-like growth factor-1R system in colorectal carcinogenesis. Crit Rev Oncol Hematol. [Epub ahead of print].

Dumont DJ, Yamaguchi P, Conlon RA, Rossant J, Breitman ML. (1992). tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene. 7:1471–1480.

Dun NJ, Dun SL, Wong RK, Förstermann U. (1994). Colocalization of nitric oxide synthase and somatostatin immunoreactivity in rat dentate hilar neurons. Proc Natl Acad Sci U S A. 91:2955-9. Du Y, Bales KR, Dodel RC, Hamilton-Byrd E, Horn JW, Czilli DL, Simmons LK, Ni B, Paul SM. (1997). Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc Natl Acad Sci U S. 94:11657-11662.

Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA. (1997). Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci. 15;17:607-14.

Dupont J, Dunn SE, Barrett JC, LeRoith D. (2003). Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression. Recent Prog Horm Res. 58:325-42.

Durai R, Yang W, Gupta S, Seifalian AM, Winslet MC. (2005). The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge.Int J Colorectal Dis. 20:203-20. Epub 2005 Jan 14.

Eckenstein F. and Thoenen H. (1982). Production of specific antisera and monoclonal antibodies to choline acetyltransferase: characterization and use for identification of cholinergic neurons.

EMBO J. 1:363-8.

Emerit MB, Riad M, Hamon M. (1992). Trophic effects of neurotransmitters during brain maturation. Biol Neonate. 62:193-201.

Epa VC. and Ward CW. (2006). Model for the complex between the insulin-like growth factor I and its receptor: towards designing antagonists for the IGF-1 receptor. Protein Eng Des Sel. 19:377- 84. Epub 2006 Jun 13.

Euler T and Wa¨ ssle H. (1995). Immunocytochemical identification of cone bipolar cells in the rat retina. J Comp Neurol. 361:461–478.

Faurobert E, Scotti A, Hurley JB, Chabre M. (1999). RET-RGS, a retina-specific regulator of G- protein signaling, is located in synaptic regions of the rat retina. Neurosci Lett. 269:41-4.

Feeney SA, Simpson DA, Gardiner TA, Boyle C, Jamison P, Stitt AW. (2003). Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci. 44:839–847.

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K.S., Powell-Braxton, L., Hillan, K.J., Moore, M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:439–442.

Folkman J. (1997). Angiogenesis and angiogenesis inhibition: an overview. EXS. 79:1–8

Fontanesi G, Gargini C, Bagnoli P. (2000). Postnatal development of somatostatin 2A (sst2A) receptors expression in the rabbit retina. Brain Res. Dev. Brain Res. 123:67-80.

Forloni G, Lucca E, Angeretti N, Chiesa R, Vezzani A (1997). Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J Neurochem. 68:319-27.

Gabriel R, de Souza S, Ziff E.B, Witkovsky P. (2002). Association of the AMPA receptor-related postsynaptic density proteins GRIP and ABP with subsets of glutamate-sensitive neurons in the rat retina. J Comp Neurol. 449:129-140.

Garcia de la Torre N, Wass JA, Turner HE. (2002). Antiangiogenic effects of somatostatin analogues. Clin Endocrinol. 57:425–441.

Ghosh KK, Bujan S, Haverkamp S, Feigenspan A, Wassle H. (2004). Types of bipolar cells in the mouse retina. J Comp Neurol. 469: 70-82.

Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME. (1998). Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 78:1017–1027.

Gillette MA. and Dacheux RF. (1995). GABA- and glycine-activated currents in the rod bipolar cell of the rabbit retina. J Neurophysiol. 74:856–875.

Gospodarowicz D, Abraham JA, Schilling J.(1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary- derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA 86:7311–7315.

Gozes I. and Brenneman DE. (2000). A new concept in the pharmacology of neuroprotection. J Mol Neurosci. 14:61-8.

Grafstein-Dunn E, Young KH, Cockett MI, Khawaja XZ. (2001). Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain. Brain Res Mol Brain Res. 88:113-23.

Grant MB. and Caballero S Jr. (2005). The potential role of octreotide in the treatment of diabetic retinopathy. Treat Endocrinol. 4:199– 203.

Greferath U, Grunert U, Wassle H. (1990). Rod bipolar cells in the mammalian retina show protein kinase C-like immunoreactivity. J Comp Neurol. 301:433-442.

Gressens P. (1998). Vasoactive intestinal peptide: a novel neurotrophic factor. Arch Pediatr. 5:654-60.

Griffioen AW. and Molema G. (2000). Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52:237–268.

Gros R, Benovic JL, Tan CM, Feldman RD. (1997). G protein–coupled receptor kinase activity is increased in hypertension. J Clin Invest. 99: 2087–2093)

Guidry C. (2005). The role of Mu¨ller cells in fibrocontractive retinal disorders. Prog Retin Eye Res. 24:75–86.

Gunn SH, Schwimer JE, Cox M, Anthony CT, O'Dorisio MS, Woltering EA. (2006). In vitro modeling of the clinical interactions between octreotide and 111In-pentetreotide: is there evidence of somatostatin receptor downregulation?. J Nucl Med. 2006 Feb;47:354-9.

Hack I, Frech M, Dick O, Peichl L, Brandsta¨ tter JH. (2001). Heterogeneous distribution of AMPA glutamate receptor subunits at the photoreceptor synapses of rodent retina. Eur J Neurosci. 13:15– 24.

Hack I, Peichl L, Brandsta¨ tter JH. (1999). An alternative pathway for rod signals in the rodent retina: rod photoreceptors, cone bipolar cells, and the localization of glutamate receptors. Proc Natl Acad Sci USA. 96: 14130–14135.

Haeseleer F, Sokal I, Verlinde CL, Erdjument-Bromage H, Tempst P, Pronin AN, Benovic JL, Fariss RN, Palczewski K (2000). Five members of a novel Ca(2+)-binding protein (CABP) subfamily with similarity to calmodulin. J Biol Chem. 275:1247-60.

Hannon JP, Nunn C, Stolz B, Bruns C, Weckbecker G, Lewis I, Troxler T, Hurth K, Hoyer D. (2002). Drug design at peptide receptors: somatostatin receptor ligands. J Mol Neurosci. 18:15-27. Hansson HA, Holmgren A, Norstedt G, Rozell B. (1989). Changes in the distribution of insulin-like growth factor I, thioredoxin, thioredoxin reductase and ribonucleotide reductase during the development of the retina. Exp Eye Res. 48:411-20

Harada C, Nakamura K, Guo X, Kitaichi N, Mitamura Y, Yoshida K, Ohno S, Yoshida H, Harada T. (2007). Neuroprotective effect of geranylgeranylacetone against ischemia-induced retinal injury. Mol Vis. 13:1601-7.

Harada C, Nakamura K, Namekata K, Okumura A, Mitamura Y, Iizuka Y, Kashiwagi K, Yoshida K, Ohno S, Matsuzawa A, Tanaka K, Ichijo H, Harada T. (2006). Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am J Pathol. 168:261-9.

Hartveit E. (1997). Functional organization of cone bipolar cells in the rat retina. J Neurophysiol. 77:1716–1730.

Hauser K & Mangoura D. (1998). Diversity of the endogenous opioid system in development. Novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation.Perspect Dev Neurobiol. 5:437-49.

Haverkamp S. and Wassle H. (2000). Immunocytochemical analysis of the mouse retina. J Comp Neurol. 424:1-23.

Haverkamp S, Grünert U, Wässle H. (2001). Localization of kainate receptors at the cone pedicles of the primate retina. J Comp Neurol. 436:471–486.

Hayar A. and Guyenet PG. (1998). Pre- and post-synaptic inhibitory actions of methionine- enkephalin on identified bulbospinal neurons of the rat RVL. J Neurophysiol. 80:2003–2014

Hayes AJ, Huang WQ, Mallah J, Yang D, Lippman ME, Li LY. (1999). Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc. Res. 58:24–237.

Heinrichs SC & Richard D. (1999) The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides. 33:350-9.

Helboe L. and Moller M. (1999). Immunoistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest Ophtalmol Vis Sci. 40:2376-82.

Helboe L. and Moller M. (2000). Localization of somatostatin receptors at the light and electron microscopial level by using antibodies raised against fusion proteins. Prog Histochem Cytochem. 35:3-64.

Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodel, L, LeRoith D, Senger DR, Smith LE. (2001). Low IGF-I suppresses VEGF- survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. USA. 98:5804–5808.

Higgins MD, Yan Y, Schrier BK. (2002). Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res. 74:553–559.

Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB. (1999). Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res.18:20 -7.

Hokfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, Diez M. (2000). Neuropeptides--an overview. Neuropharmacology. 39:1337-56.

Hokfelt T, Pernow B, Wahren J. (2001). Substance P: a pioneer amongst neuropeptides. J Intern

Nel documento AZIONE NEUROPROTETTIVA ED ANTIANGIOGENICA DELLA SOMATOSTATINA NELLA RETINA:IL COINVOLGIMENTO DEL SOTTOTIPO RECETTORIALE 2 DELLA SOMATOSTATINA (pagine 123-149)